Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance

Background: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with a spectrum of presentation. Studies have reported considerably different rates in terms of the incidence of polycystic ovary morphology (PCOM) in patients with PCOS with inconsistent results regarding the effects of PCOM i...

Full description

Saved in:
Bibliographic Details
Main Authors: Sweekruti Jena, Ipsita Mishra, Anoj Kumar Baliarsinha, Debarchan Jena, Madhumita Debata
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-04-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:https://journals.lww.com/10.4103/jhrs.jhrs_60_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860952860196864
author Sweekruti Jena
Ipsita Mishra
Anoj Kumar Baliarsinha
Debarchan Jena
Madhumita Debata
author_facet Sweekruti Jena
Ipsita Mishra
Anoj Kumar Baliarsinha
Debarchan Jena
Madhumita Debata
author_sort Sweekruti Jena
collection DOAJ
description Background: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with a spectrum of presentation. Studies have reported considerably different rates in terms of the incidence of polycystic ovary morphology (PCOM) in patients with PCOS with inconsistent results regarding the effects of PCOM in them. Aims: The aim of this study was to determine the differences in clinical presentation, metabolic profile, hormonal parameters and inflammatory markers in PCOS women with and without PCOM on ultrasonography (USG). Settings and Design: A total of 70 PCOS women were recruited. To analyse the differences between various parameters, the patients were divided into two groups based on the presence or absence of PCOM on USG of the pelvis as per the Rotterdam criteria. Materials and Methods: A total of 37 patients had PCOM as per the diagnostic criteria for PCOS (Group 1), while 33 patients did not have PCOM on USG and were designated as Group 2. All participants underwent a detailed clinical evaluation and biochemical investigations, including high-sensitivity C-reactive protein, serum adiponectin, luteinising hormone, follicle-stimulating hormone, total testosterone and serum anti-Mullerian hormone. The homeostasis model assessment of IR (HOMA-IR) was calculated using standard equations. Statistical Analysis Used: The mean and Standard deviation were computed for all continuous variables. Frequencies and proportions were calculated for categorical variables. Comparisons of the mean scores between the study groups were assessed using the Unpaired Student's t-test. The mean score of the subgroups was also compared using the unpaired Student's t-test. P < 0.05 was considered significant for all statistical inferences. Results: The mean LDL and mean triglyceride were higher in Group 2, which was statistically significant (P = 0.004 and P ≤ 0.001, respectively). The mean hs-CRP was found to be higher in Group 2, which was statistically significant (P = 0.005). The mean AMH was higher in Group 1, which was statistically significant (P = 0.002). Group 1 had higher adiponectin levels, which was statistically significant (P = 0.04). Conclusion: The above findings suggest that patients without diagnostic PCO morphology have a worse metabolic profile compared to those with PCO morphology on USG. Obese patients without PCO morphology probably have a higher cardiovascular risk compared to obese patients with PCO morphology.
format Article
id doaj-art-485796eebbbd4530bad7fd05908df12d
institution Kabale University
issn 0974-1208
1998-4766
language English
publishDate 2023-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Human Reproductive Sciences
spelling doaj-art-485796eebbbd4530bad7fd05908df12d2025-02-10T07:43:52ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662023-04-0116213213910.4103/jhrs.jhrs_60_23Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology AppearanceSweekruti JenaIpsita MishraAnoj Kumar BaliarsinhaDebarchan JenaMadhumita DebataBackground: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder with a spectrum of presentation. Studies have reported considerably different rates in terms of the incidence of polycystic ovary morphology (PCOM) in patients with PCOS with inconsistent results regarding the effects of PCOM in them. Aims: The aim of this study was to determine the differences in clinical presentation, metabolic profile, hormonal parameters and inflammatory markers in PCOS women with and without PCOM on ultrasonography (USG). Settings and Design: A total of 70 PCOS women were recruited. To analyse the differences between various parameters, the patients were divided into two groups based on the presence or absence of PCOM on USG of the pelvis as per the Rotterdam criteria. Materials and Methods: A total of 37 patients had PCOM as per the diagnostic criteria for PCOS (Group 1), while 33 patients did not have PCOM on USG and were designated as Group 2. All participants underwent a detailed clinical evaluation and biochemical investigations, including high-sensitivity C-reactive protein, serum adiponectin, luteinising hormone, follicle-stimulating hormone, total testosterone and serum anti-Mullerian hormone. The homeostasis model assessment of IR (HOMA-IR) was calculated using standard equations. Statistical Analysis Used: The mean and Standard deviation were computed for all continuous variables. Frequencies and proportions were calculated for categorical variables. Comparisons of the mean scores between the study groups were assessed using the Unpaired Student's t-test. The mean score of the subgroups was also compared using the unpaired Student's t-test. P < 0.05 was considered significant for all statistical inferences. Results: The mean LDL and mean triglyceride were higher in Group 2, which was statistically significant (P = 0.004 and P ≤ 0.001, respectively). The mean hs-CRP was found to be higher in Group 2, which was statistically significant (P = 0.005). The mean AMH was higher in Group 1, which was statistically significant (P = 0.002). Group 1 had higher adiponectin levels, which was statistically significant (P = 0.04). Conclusion: The above findings suggest that patients without diagnostic PCO morphology have a worse metabolic profile compared to those with PCO morphology on USG. Obese patients without PCO morphology probably have a higher cardiovascular risk compared to obese patients with PCO morphology.https://journals.lww.com/10.4103/jhrs.jhrs_60_23adiponectinhigh-sensitivity c-reactive proteinhomeostasis model assessment of insulin resistancepolycystic ovarian morphologypolycystic ovary syndrome
spellingShingle Sweekruti Jena
Ipsita Mishra
Anoj Kumar Baliarsinha
Debarchan Jena
Madhumita Debata
Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
Journal of Human Reproductive Sciences
adiponectin
high-sensitivity c-reactive protein
homeostasis model assessment of insulin resistance
polycystic ovarian morphology
polycystic ovary syndrome
title Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
title_full Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
title_fullStr Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
title_full_unstemmed Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
title_short Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
title_sort variation in clinical presentation metabolic profile hormonal parameters and inflammatory markers in polycystic ovary syndrome women with and without polycystic ovary morphology appearance
topic adiponectin
high-sensitivity c-reactive protein
homeostasis model assessment of insulin resistance
polycystic ovarian morphology
polycystic ovary syndrome
url https://journals.lww.com/10.4103/jhrs.jhrs_60_23
work_keys_str_mv AT sweekrutijena variationinclinicalpresentationmetabolicprofilehormonalparametersandinflammatorymarkersinpolycysticovarysyndromewomenwithandwithoutpolycysticovarymorphologyappearance
AT ipsitamishra variationinclinicalpresentationmetabolicprofilehormonalparametersandinflammatorymarkersinpolycysticovarysyndromewomenwithandwithoutpolycysticovarymorphologyappearance
AT anojkumarbaliarsinha variationinclinicalpresentationmetabolicprofilehormonalparametersandinflammatorymarkersinpolycysticovarysyndromewomenwithandwithoutpolycysticovarymorphologyappearance
AT debarchanjena variationinclinicalpresentationmetabolicprofilehormonalparametersandinflammatorymarkersinpolycysticovarysyndromewomenwithandwithoutpolycysticovarymorphologyappearance
AT madhumitadebata variationinclinicalpresentationmetabolicprofilehormonalparametersandinflammatorymarkersinpolycysticovarysyndromewomenwithandwithoutpolycysticovarymorphologyappearance